# clm_FD718C31F784

subject: AbbVie (/record/abbvie.md)  
predicate: quarterly_operating_income  
value: 4,513,000,000 United States dollar  
valid_from: 2023-06-30  
valid_to: 2023-09-30  
published: 2023-08-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A6F43E732D82  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie quarterly operating income: 4,513,000,000 United States dollar", as of 2023-06-30 (until 2023-09-30). Claim clm_FD718C31F784, https://asof.is/claim/clm_FD718C31F784, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/0001551152-23-000033-index.htm (primary, SEC EDGAR 10-Q Q2 FY2023, published 2023-08-07)

## Supersedes

- [AbbVie](/record/abbvie.md) | quarterly_operating_income | 2,768,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_FD718C31F784](/claim/clm_FD718C31F784.md) | [clm_C0D9B2A2E414](/claim/clm_C0D9B2A2E414.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.